Smith Jason Drew
UroGen Pharma Ltd. ยท General Counsel
Smith Jason Drew is listed in public filings as officer: General Counsel. This Smith Jason Drew insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include UroGen Pharma Ltd. (URGN). Investors use Smith Jason Drew's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.1M55.6k shares | SellFeb 3, 2026 | $63.3K3.2k shares | $19.69 | -- | |
| $1.0M52.9k shares | SellFeb 3, 2026 | $52.3K2.7k shares | $19.69 | -- | |
| $1.0M51.3k shares | SellFeb 3, 2026 | $31.7K1.6k shares | $19.69 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --6.7k shares | Grant / ExerciseJan 31, 2026 | Disclosure amount unavailable6.7k shares | -- | -- | |
| --5.5k shares | Grant / ExerciseJan 31, 2026 | Disclosure amount unavailable5.5k shares | -- | -- | |
| --6.7k shares | Grant / ExerciseJan 31, 2026 | Disclosure amount unavailable3.3k shares | -- | -- | |
| --32.6k shares | Grant / ExerciseJan 31, 2026 | Disclosure amount unavailable32.6k shares | -- | -- | |
| $828k43.3k shares | SellSep 8, 2025 | $29.0K1.5k shares | $19.11 | -- | |
| --3.3k shares | Grant / ExerciseSep 7, 2025 | Disclosure amount unavailable3.3k shares | -- | -- | |
| --49k shares | Grant / ExerciseJul 28, 2025 | Disclosure amount unavailable16.5k shares | -- | -- | |
| $794k41.5k shares | SellJul 28, 2025 | $144.0K7.5k shares | $19.14 | -- | |
| --2.5k shares | Grant / ExerciseJan 31, 2025 | Disclosure amount unavailable2.5k shares | -- | -- | |
| --6.7k shares | Grant / ExerciseJan 31, 2025 | Disclosure amount unavailable6.7k shares | -- | -- | |
| --10k shares | Grant / ExerciseJan 31, 2025 | Disclosure amount unavailable10k shares | -- | -- | |
| --11k shares | Grant / ExerciseJan 31, 2025 | Disclosure amount unavailable5.5k shares | -- | -- | |
| $332k29.8k shares | SellJan 31, 2025 | $37.4K3.4k shares | $11.14 | -- | |
| $362k32.5k shares | SellJan 31, 2025 | $30.8K2.8k shares | $11.14 | -- | |
| $295k26.5k shares | SellJan 31, 2025 | $14.0K1.3k shares | $11.14 | -- | |
| --6.7k shares | Grant / ExerciseSep 9, 2024 | Disclosure amount unavailable3.3k shares | -- | -- | |
| $330k25.2k shares | SellSep 9, 2024 | $19.9K1.5k shares | $13.08 | -- |